🆒 Couldn't attend my #EULAR2022 talk about the role of #twitter in #Rheumatology? Check the 2 slides below summarizing the role of #socialmedia for the dissemination of medical information. #TwitterRheum ⬇️ BEFORE vs AFTER Twitter ⬇️ https://t.co/ZzVdoWYEMr

EULAR recommendations for management of #RheumatoidArthritis 6️⃣Glucocorticoids should be tapered & discontinued as soon as clinically feasible 8️⃣JAKi can be used but consider risk factors via Prof Smolen #EULAR2022 https://t.co/7cocPSpgkH

#ClinicalPearl Oral Surveillance chance of having a MACE was highest....you guessed it, in those with past MACE events. Some CV risks have different risks ex HTN May have less risk vs high cholesterol @RheumNow @eular_org #EULAR2022 POS0237 https://t.co/kTn4rxMlej

Watch: #EULAR2022 - Day 4 Faculty Panel Recap Dr. David Liew and Dr. Jack Cush discuss day 4 of EULAR 2022. LB0001, LB0002, LB0004, and LB0006. https://t.co/B7AYkTnAe0 https://t.co/NF3f6AFv6K

Update on Axial SpA at #EULAR2022 This year at EULAR 2022, there were important and interesting topics in Axial Spondyloarthritis (AxSpA). Dr Antoni Chan shares his picks of abstracts from the conference. https://t.co/AhUC7ORrZi https://t.co/1olLoNS5Ey

#EULAR2022 – Day 4 Report Check out our my favorite late-breakers from Day 4. https://t.co/R0hPetOos4 https://t.co/T57XRIKZs5

Spondyloarthritis and COVID-19 With the availability of vaccines and new therapeutics, many of our patients are fully vaccinated. We know this can limit their chances of severe COVID all while allowing their rheumatic disease to be treated. #EULAR2022 https://t.co/PmQNKYg1Ao https://t.co/N4DJVYJqrL

WATCH: Not Your Kind of RA Dr. David Liew discusses abstract OP0035 presented at #EULAR2022 Background: It has been suggested that rheumatoid arthritis (RA) starts at a younger age in cities with a lower latitude (closer to both sides of the equator). https://t.co/0l8b95emkn https://t.co/2leBR1nOBJ